Grantee Name: Prof. Liran Shlush
Organization: Weizmann Institute of Science
Country: Israel
Project Name:
Early diagnosis and treatment of pre-leukemia
Funding Year: 2018
Project period: 5 years
Early diagnosis and treatment of pre-leukemia
Currently, there is no reliable method to identify which patients with age-related clonal hematopoiesis (ARCH) will develop acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Based on preliminary data, the investigators propose to identify and treat high-risk individuals with ARCH, before they have developed the disease.